Stay updated on Dose effect of HSV-2 therapy on HSV and HIV Clinical Trial
Sign up to get notified when there's something new on the Dose effect of HSV-2 therapy on HSV and HIV Clinical Trial page.

Latest updates to the Dose effect of HSV-2 therapy on HSV and HIV Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a new Revision: v3.4.2 banner and removed the previous government-funding/operating-status notice associated with Revision: v3.4.1.SummaryDifference0.4%

- Check22 days agoChange DetectedAdded a global notice about government funding lapse and NIH Clinical Center operating status with links to cc.nih.gov and opm.gov. Updated the page revision tag from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check29 days agoChange DetectedAdded a glossary display option and a QC-status indicator; updated the page revision to v3.4.0 and adjusted capitalization of No FEAR Act terms.SummaryDifference0.2%

- Check36 days agoChange DetectedA large number of core terms and sections central to the study record have been deleted, including disease names, treatments, eligibility criteria, location details, and investigators. This reduces the page's clarity and navigability.SummaryDifference17%

- Check43 days agoChange DetectedThe page now displays Revision: v3.3.4 instead of v3.3.3.SummaryDifference0.1%

- Check65 days agoChange DetectedAdded a Locations section with a new site in Seattle, Washington. Washington is now listed as a study location.SummaryDifference0.2%

Stay in the know with updates to Dose effect of HSV-2 therapy on HSV and HIV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dose effect of HSV-2 therapy on HSV and HIV Clinical Trial page.